UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Quarter of drugs winning fast-track approvals not supplied at all’
by Lee Hye-seon
2017-10-17 16:34
TissueGene promotes cell gene therapy Invossa ahead of IPO
by Lee Hye-seon
2017-10-17 14:32
Mandatory drug labeling of all ingredients to start in December
by Lee Hye-seon
2017-10-16 15:33
2 orphan drugs find manufacturers in Korea
by Lee Hye-seon
2017-10-12 15:48
Boryung to sell antihypertensive drugs in SE Asia
by Lee Hye-seon
2017-10-11 16:02
라인
Samsung Bioepis teams up with Yuhan for biosimilars
by Lee Hye-seon
2017-10-11 14:25
Anticorruption law changes drugmakers, salespersons
by Lee Hye-seon
2017-09-28 17:14
Korean combos, incrementally modified drugs to get insurance benefits
by Lee Hye-seon
2017-09-27 11:29
72 drugs should warn against autoimmunity muscle disease
by Lee Hye-seon
2017-09-25 15:30
Chong Kun Dang, Daewoong continue to fight over Gliatilin reference listed drug
by Lee Hye-seon
2017-09-22 12:17
라인
Samsung Bioepis gets additional approval for its biosimilar
by Lee Hye-seon
2017-09-21 12:03
Big data behind CJ’s development of new drug
by Lee Hye-seon
2017-09-20 12:05
Prices of Viread's modified drugs plunge over past month
by Lee Hye-seon
2017-09-19 17:22
Korean pharmaceuticals challenge Pfizer’s Viviant with combination drugs
by Lee Hye-seon
2017-09-18 11:26
Kolon uses Invossa to attract foreign patients
by Lee Hye-seon
2017-09-15 17:49
라인
SK Chemicals’ release of test result abroad raises curiosity
by Lee Hye-seon
2017-09-15 17:39
Hanmi releases research result of new bio drug in Europe
by Lee Hye-seon
2017-09-15 14:32
LG Chem promotes antidiabetic Zemiglo in Europe
by Lee Hye-seon
2017-09-15 11:51
Chong Kun Dang enters an osteoporosis therapy market
by Lee Hye-seon
2017-09-14 17:53
Severance Hospital revamps emergency care center
by Lee Hye-seon
2017-09-13 16:08
-
이전
11
12
13
14
15
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top